[1]
|
Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[2]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[3]
|
Zhou, M., Wang, H., Zeng, X., Yin, P., Zhu, J., Chen, W., et al. (2019) Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet, 394, 1145-1158. https://doi.org/10.1016/S0140-6736(19)30427-1
|
[4]
|
Llovet, J.M., Real, M.I., Montana, X., Planas, R., Coll, S., Aponte, J., et al. (2002) Arterial Embolisation or Chemoembolisation versus Symptomatic Treatment in Patients with Unresectable Hepatocellular Carcinoma: A Randomised Controlled Trial. Lancet, 359, 1734-1739. https://doi.org/10.1016/S0140-6736(02)08649-X
|
[5]
|
Lencioni, R., de Baere, T., Soulen, M.C., Rilling, W.S. and Geschwind, J.F. (2016) Lipiodol Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review of Efficacy and Safety Data. Hepatology, 64, 106-116. https://doi.org/10.1002/hep.28453
|
[6]
|
Lo, C.M., Ngan, H., Tso, W.K., Liu, C.L., Lam, C.M., Poon, R.T., et al. (2002) Randomized Controlled Trial of Transarterial Lipiodol Chemoembolization for Unresectable Hepatocellular Carcinoma. Hepatology, 35, 1164-1171. https://doi.org/10.1053/jhep.2002.33156
|
[7]
|
Llovet, J.M. and Bruix, J. (2003) Systematic Review of Randomized Trials for Unresectable Hepatocellular Carcinoma: Chemoembolization Improves Survival. Hepatology, 37, 429-442. https://doi.org/10.1053/jhep.2003.50047
|
[8]
|
Camma, C., Schepis, F., Orlando, A., Albanese, M., Shahied, L., Trevisani, F., et al. (2002) Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials. Radiology, 224, 47-54. https://doi.org/10.1148/radiol.2241011262
|
[9]
|
Pelletier, G., Ducreux, M., Gay, F., Luboinski, M., Hagege, H., Dao, T., et al. (1998) Treatment of Unresectable Hepatocellular Carcinoma with Lipiodol Chemoembolization: A Multicenter Randomized trial. Journal of Hepatology, 29, 129-134. https://doi.org/10.1016/S0168-8278(98)80187-6
|
[10]
|
Dezso, K., Bugyik, E., Papp, V., Laszlo, V., Dome, B., Tovari, J., et al. (2009) Development of Arterial Blood Supply in Experimental Liver Metastases. The American Journal of Pathology, 175, 835-843. https://doi.org/10.2353/ajpath.2009.090095
|
[11]
|
Park, Y.N., Yang, C.P., Fernandez, G.J., Cubukcu, O., Thung, S.N. and Theise, N.D. (1998) Neoangiogenesis and Sinusoidal “Capillarization” in Dysplastic Nodules of the Liver. The American Journal of Surgical Pathology, 22, 656-662. https://doi.org/10.1097/00000478-199806000-00002
|
[12]
|
Sigurdson, E.R., Ridge, J.A., Kemeny, N. and Daly, J.M. (1987) Tumor and Liver Drug Uptake Following Hepatic Artery and Portal Vein Infusion. Journal of Clinical Oncology, 5, 1836-1840. https://doi.org/10.1200/JCO.1987.5.11.1836
|
[13]
|
Llovet, J.M., Burroughs, A. and Bruix, J. (2003) Hepatocellular Carcinoma. Lancet, 362, 1907-1917. https://doi.org/10.1016/S0140-6736(03)14964-1
|
[14]
|
Ruan, J.Y., Lin, J.T., Xiong, Y., Chen, Z.Z., Chen, J.H. and Yu, H.J. (2020) Clinical Characteristics of Transarterial Chemoembolization in Treatment of Primary Hepatocellular Carcinoma Complicated With Respiratory Distress Syndrome. Technology in Cancer Research & Treatment, 19, Article ID: 970673. https://doi.org/10.1177/1533033820970673
|
[15]
|
Silvestri, R.C., Huseby, J.S., Rughani, I., Thorning, D. and Culver, B.H. (1980) Respiratory Distress Syndrome from Lymphangiography Contrast Medium. American Review of Respiratory Disease, 122, 543-549.
|
[16]
|
Lv, N., Kong, Y., Mu, L., Pan, T., Xie, Q. and Zhao, M. (2016) Effect of Perioperative Parecoxib Sodium on Postoperative Pain Control for Transcatheter Arterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Prospective Randomized Trial. European Radiology, 26, 3492-3499. https://doi.org/10.1007/s00330-016-4207-8
|
[17]
|
Guan, H.T., Wang, J., Yang, M., Song, L., Tong, X.Q. and Zou, Y.H. (2013) Changes in Immunological Function after Treatment with Transarterial Chemoembolization plus Radiofrequency Ablation in Hepatocellular Carcinoma Patients. Chinese Medical Journal, 126, 3651-3655.
|
[18]
|
Xu, H., Yang, R., Wang, X., Zhu, X. and Chen, H. (2014) Symptomatic Pulmonary Lipiodol Embolism after Transarterial Chemoembolization for Hepatic Malignant Tumor: Clinical Presentation and Chest Imaging Findings. Chinese Medical Journal, 127, 675-679.
|
[19]
|
Tajima, T., Honda, H., Kuroiwa, T., Yabuuchi, H., Okafuji, T., Yosimitsu, K., et al. (2002) Pulmonary Complications after Hepatic Artery Chemoembolization or Infusion via the Inferior Phrenic Artery for Primary Liver Cancer. Journal of Vascular and Interventional Radiology, 13, 893-900. https://doi.org/10.1016/S1051-0443(07)61772-2
|
[20]
|
Chung, J.W., Park, J.H., Im, J.G., Han, J.K. and Han, M.C. (1993) Pulmonary Oil Embolism after Transcatheter Oily Chemoembolization of Hepatocellular Carcinoma. Radiology, 187, 689-693. https://doi.org/10.1148/radiology.187.3.8388567
|
[21]
|
Wu, G.C., Perng, W.C., Chen, C.W., Chian, C.F., Peng, C.K. and Su, W.L. (2009) Acute Respiratory Distress Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinomas. The American Journal of the Medical Sciences, 338, 357-360. https://doi.org/10.1097/MAJ.0b013e3181b15625
|
[22]
|
Kan, Z., Ivancev, K., Hagerstrand, I., Chuang, V.P. and Lunderquist, A. (1989) In Vivo Microscopy of the Liver after Injection of Lipiodol into the Hepatic Artery and Portal Vein in the Rat. Acta Radiologica, 30, 419-425. https://doi.org/10.1177/028418518903000418
|
[23]
|
Lee, J.H., Won, J.H., Park, S.I., Won, J.Y., Lee, D.Y. and Kang, B.C. (2007) Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma with Hepatic Arteriovenous Shunt after Temporary Balloon Occlusion of Hepatic Vein. Journal of Vascular and Interventional Radiology, 18, 377-382. https://doi.org/10.1016/j.jvir.2007.01.005
|
[24]
|
Wu, J.J., Chao, M., Zhang, G.Q., Li, B. and Dong, F. (2009) Pulmonary and Cerebral Lipiodol Embolism after Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma. World Journal of Gastroenterology, 15, 633-635. https://doi.org/10.3748/wjg.15.633
|
[25]
|
Fang, L.J., Chen, L.Y., Sun, J.H. and Zhou, J.Y. (2019) Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China. Analytical Cellular Pathology, 2019, Article ID: 4307651. https://doi.org/10.1155/2019/4307651
|
[26]
|
Murata, S., Tajima, H., Nakazawa, K., Onozawa, S., Kumita, S. and Nomura, K. (2009) Initial Experience of Transcatheter Arterial Chemoembolization during Portal Vein Occlusion for Unresectable Hepatocellular Carcinoma with Marked Arterioportal Shunts. European Radiology, 19, 2016-2023. https://doi.org/10.1007/s00330-009-1349-y
|
[27]
|
Tarazov, P.G. (1993) Intrahepatic Arterioportal Fistulae: Role of Transcatheter Embolization. Cardiovascular and Interventional Radiology, 16, 368-373. https://doi.org/10.1007/BF02603142
|
[28]
|
Furuse, J., Iwasaki, M., Yoshino, M., Konishi, M., Kawano, N., Kinoshita, T., et al. (1997) Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Embolization of Arterioportal Shunts. Radiology, 204, 787-790. https://doi.org/10.1148/radiology.204.3.9280260
|
[29]
|
Kim, Y.J., Lee, H.G., Park, J.M., Lim, Y.S., Chung, M.H., Sung, M.S., et al. (2007) Polyvinyl Alco-hol Embolization Adjuvant to Oily Chemoembolization in Advanced Hepatocellular Carcinoma with Arterioportal Shunts. Korean Journal of Radiology, 8, 311-319. https://doi.org/10.3348/kjr.2007.8.4.311
|
[30]
|
Wu, J.J., Chao, M., Zhang, G.Q., Li, B. and Dong, F. (2009) Pulmonary and Cerebral Lipiodol Embolism after Transcatheter Arterial Hemoembolization in Hepatocellular Carcinoma. World Journal of Gastroenterology, 15, 633-635. https://doi.org/10.3748/wjg.15.633
|
[31]
|
Kim, H.C., Chung, J.W., Lee, W., Jae, H.J. and Park, J.H. (2005) Recognizing Extrahepatic Collateral Vessels That Supply Hepatocellular Carcinoma to Avoid Complications of Transcatheter Arterial Chemoembolization. Radiographics, 25, S25-S39. https://doi.org/10.1148/rg.25si055508
|
[32]
|
Ishimaru, H., Morikawa, M., Sakugawa, T., Sakamoto, I., Motoyoshi, Y., Ikebe, Y., et al. (2018) Cerebral Lipiodol Embolism Related to a Vascular Lake during Chemoembolization in Hepatocellular Carcinoma: A Case Report and Review of the Literature. World Journal of Gastroenterology, 24, 4291-4296. https://doi.org/10.3748/wjg.v24.i37.4291
|
[33]
|
Wu, R.H., Tzeng, W.S. and Chang, C.M. (2005) Iodized Oil Embolization to Brain Following Transcatheter Arterial Embolization of Liver. Journal of Gastroenterology and Hepatology, 20, 1465-1467. https://doi.org/10.1111/j.1440-1746.2005.03412.x
|
[34]
|
Choi, C.S., Kim, K.H., Seo, G.S., Cho, E.Y., Oh, H.J., Choi, S.C., et al. (2008) Cerebral and Pulmonary Embolisms after Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma. World Journal of Gastroenterology, 14, 4834-4837. https://doi.org/10.3748/wjg.14.4834
|
[35]
|
Sakamoto, I., Aso, N., Nagaoki, K., Matsuoka, Y., Uetani, M., Ashizawa, K., et al. (1998) Complications Associated with Transcatheter Arterial Embolization for Hepatic Tumors. Radiographics, 18, 605-619. https://doi.org/10.1148/radiographics.18.3.9599386
|
[36]
|
Watanabe, Y., Tokue, H., Taketomi-Takahashi, A. and Tsushima, Y. (2018) Imaging Findings and Complications of Transcatheter Interventional Treatments via the Inferior Phrenic Arteries in Patients with Hepatocellular Carcinoma. European Journal of Radiology Open, 5, 171-176. https://doi.org/10.1016/j.ejro.2018.08.010
|
[37]
|
Hatamaru, K., Azuma, S., Akamatsu, T., Seta, T., Urai, S., Uenoyama, Y., et al. (2015) Pulmonary Embolism after Arterial Chemoembolization for Hepatocellular Carcinoma: An Autopsy Case Report. World Journal of Gastroenterology, 21, 1344-1348. https://doi.org/10.3748/wjg.v21.i4.1344
|
[38]
|
Vahid, B. and Marik, P.E. (2008) Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies. Canadian Respiratory Journal, 15, 211-216. https://doi.org/10.1155/2008/305234
|
[39]
|
Minchin, R.F., Johnston, M.R., Schuller, H.M., Aiken, M.A. and Boyd, M.R. (1988) Pulmonary Toxicity of Doxorubicin Administered by in situ Isolated Lung Perfusion in Dogs. Cancer, 61, 1320-1325. https://doi.org/10.1002/1097-0142(19880401)61:7<1320::AID-CNCR2820610708>3.0.CO;2-J
|
[40]
|
Khan, I., Vasudevan, V., Nallagatla, S., Arjo-mand, F. and Ali, R. (2012) Acute Lung Injury Following Transcatheter Hepatic Arterial Chemoembolization of Doxorubicin-Loaded LC Beads in a Patient with Hepatocellular Carcinoma. Lung India, 29, 169-172. https://doi.org/10.4103/0970-2113.95335
|
[41]
|
Aladdin, M. and Ilyas, M. (2011) Chemoembolization of Hepatocellular Carcinoma with Drug-Eluting Beads Complicated by Interstitial Pneumonitis. Seminars in Interventional Radiology, 28, 218-221. https://doi.org/10.1055/s-0031-1280668
|
[42]
|
Jacobs, C., Slade, M. and Lavery. B. (2002) Doxorubicin and BOOP. A Possible Near Fatal Association. Clinical Oncology, 14, 262. https://doi.org/10.1053/clon.2002.0071
|
[43]
|
Vahid, B. and Marik, P.E. (2008) Pulmonary Complications of Novel Antineoplastic Agents for Solid Tumors. Chest, 133, 528-538. https://doi.org/10.1378/chest.07-0851
|
[44]
|
Lin, M.T. and Kuo, P.H. (2010) Pulmonary Lipiodol Embolism after Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma. JRSM Open, 1, 1-4. https://doi.org/10.1258/shorts.2009.090352
|
[45]
|
Wu, G.C., Chan, E.D., Chou, Y.C., Yu, C.Y., Hsieh, T.Y., Hsieh, C.B., et al. (2014) Risk Factors for the Development of Pulmonary Oil Embolism after Transcatheter Arterial Chemoembolization of Hepatic Tumors. Anticancer Drugs, 25, 976-981. https://doi.org/10.1097/CAD.0000000000000113
|
[46]
|
Cheng, H.Y., Shou, Y., Wang, X., Xu, A.M., Chen, D. and Jia, Y.C. (2004) Adjustment of Lipiodol Dose According to Tumor Blood Supply during Transcatheter Arterial Chemoembolization for Large Hepatocellular Carcinoma by Multidetector Helical CT. World Journal of Gastroenterologyl, 10, 2753-2755. https://doi.org/10.3748/wjg.v10.i18.2753
|
[47]
|
Nakao, N., Uchida, H., Kamino, K., Nishimura, Y., Ohishi, H., Takayasu, Y., et al. (1994) Determination of the Optimum Dose Level of Lipiodol in Transcatheter Arterial Embolization of Primary Hepatocellular Carcinoma Based on Retrospective Multivariate Analysis. Cardiovascular and Interventional Radiology, 17, 76-80. https://doi.org/10.1007/BF00193921
|
[48]
|
Padia, S.A., Shivaram, G., Bastawrous, S., Bhargava, P., Vo, N.J., Vaidya, S., et al. (2013) Safety and Efficacy of Drug-Eluting Bead Chemoembolization for Hepatocellular Carcinoma: Comparison of Small-versus Medium-Size Particles. Journal of Vascular and Interventional Radiology, 24, 301-306. https://doi.org/10.1016/j.jvir.2012.11.023
|
[49]
|
Prajapati, H.J., Xing, M., Spivey, J.R., Hanish, S.I., El-Rayes, B.F., Kauh, J.S., et al. (2014) Survival, Efficacy, and Safety of Small versus Large Doxorubicin Drug-Eluting Beads TACE Chemoembolization in Patients with Unresectable HCC. American Journal of Roentgenology, 203, W706-W714. https://doi.org/10.2214/AJR.13.12308
|
[50]
|
Brown, K.T. (2004) Fatal Pulmonary Complications after Arterial Embolization with 40 - 120 μm Tris-Acryl Gelatin Microspheres. Journal of Vascular and Interventional Radiology, 15, 197-200. https://doi.org/10.1097/01.RVI.0000109400.52762.1F
|
[51]
|
Albrecht, M.H., Bickford, M.W., Nance, J.W., Zhang, L., De Cecco, C.N., Wichmann, J.L., et al. (2017) State-of-the-Art Pulmonary CT Angiography for Acute Pulmonary Embolism. American Journal of Roentgenology, 208, 495-504. https://doi.org/10.2214/AJR.16.17202
|
[52]
|
Ranieri, V.M., Rubenfeld, G.D., Thompson, B.T., Ferguson, N.D., Caldwell, E., Fan, E., et al. (2012) Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA, 307, 2526-2533. https://doi.org/10.1001/jama.2012.5669
|
[53]
|
Modrykamien, A.M. and Gupta, P. (2015) The Acute Respiratory Distress Syndrome. Baylor University Medical Center Proceedings, 28, 163-171. https://doi.org/10.1080/08998280.2015.11929219
|
[54]
|
Habashi, N.M., Andrews, P.L. and Scalea, T.M. (2006) Therapeutic Aspects of Fat Embolism Syndrome. Injury, 37, S68-S73. https://doi.org/10.1016/j.injury.2006.08.042
|
[55]
|
Taupin, D., Mukherjee, V., Nathavitharana, R., Green, D.A. and Fridman, D. (2014) Lipiodol Embolism Following Transarterial Chemoembolization: An Atypical Case. Critical Care Medicine, 42, e481-e484. https://doi.org/10.1097/CCM.0000000000000307
|
[56]
|
Alifakioti, D., Daccord, C., Lachenal, Y. and Fitting, J.W. (2014) Acute Eosinophilic and Neutrophilic Pneumonia Following Transarterial Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin for Hepatocellular Carcinoma: A Case Report. Respiration, 88, 426-429. https://doi.org/10.1159/000367814
|
[57]
|
Nhu, Q.M., Knowles, H., Pockros, P.J. and Frenette, C.T. (2016) An Unexpected Pulmonary Complication Following Transcatheter Arterial Chemoembolization of a Small Hepatocellular Carcinoma. Journal of Clinical Gastroenterology, 50, 524-525. https://doi.org/10.1097/MCG.0000000000000524
|